In GBM the TGF-β pathway is dysregulated and contributes to pathogenesis and progression.143 GBM cells have been shown to secrete TGF-β2 that also suppresses the anti-GBM immune response.146. The gene discussed is TGFB2; the disease is glioblastoma.